[1] HUA Q, FAN L, LI J. Joint Committee for Guideline R. 2019 Chinese guideline for the management of hypertension in the elderly[J]. J Geriatr Cardiol,2019,16(2):67-99. [2] LEONG D P, TEO K K, RANGARAJAN S, et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study[J]. Lancet,2015,386(9990):266-273. [3] PRASITSIRIPHON O, POTHISIRI W. Associations of grip strength and change in grip strength with all-cause and cardiovascular mortality in a European older population[J]. Clin Med Insights Cardiol,2018,12:1179546818771894. [4] BAE E J, PARK N J, SOHN H S, et al. Handgrip strength and all-cause mortality in middle-aged and older Koreans[J]. Int J Environ Res Public Health,2019,16(5):740. [5] ARTERO E G, LEE D C, RUIZ J R, et al. A prospective study of muscular strength and all-cause mortality in men with hypertension[J]. J Am Coll Cardiol,2011,57(18):1831-1837. [6] Joint Committee for Guideline Revision. 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension[J]. J Geriatr Cardiol,2019,16(3):182-241. [7] 全国eGFR课题协作组. MDRD方程在我国慢性肾脏病患者中的改良和评估[J].中华肾脏病杂志,2006,22(10):589-595. [8] CHARLSON M E, POMPEI P, ALES K L, et al.A new method of classifying prognostic comorbidity in longitudinal studies: development and validation[J]. J Chronic Dis,1987,40(5):373-383. [9] KAISER M J, BAUER J M, RAMSCH C,et al. Validation of the Mini Nutritional Assessment short-form (MNA-SF): a practical tool for identification of nutritional status[J]. J Nutr Health Aging,2009,13(9):782-788. [10] 中国老年医学学会高血压分会, 国家老年疾病临床医学研究中心中国老年心血管病防治联盟. 中国老年高血压管理指南2019[J].中国心血管杂志, 2019,24(1):1-23. [11] SAYER A A, KIRKWOOD T B. Grip strength and mortality: a biomarker of ageing?[J]. Lancet,2015, 386(9990):226-227. [12] 张丹丹, 张洁. 住院老年病人衰弱早期识别与评估的研究进展[J].实用老年医学,2018, 32(9):884-886. [13] CELIS-MORALES C A, WELSH P, LYALL D M, et al. Associations of grip strength with cardiovascular, respiratory, and cancer outcomes and all cause mortality: prospective cohort study of half a million UK Biobank participants[J]. BMJ,2018,361:k1651. [14] GRANIC A, DAVIES K, JAGGER C, et al. Initial level and rate of change in grip strength predict all-cause mortality in very old adults[J]. Age Ageing,2017,46(6):970-976. [15] HERNANDEZ-LUIS R, MARTIN-PONCE E, MONEREO-MUNOZ M, et al. Prognostic value of physical function tests and muscle mass in elderly hospitalized patients. A prospective observational study[J]. Geriatr Gerontol Int,2018,18(1):57-64. [16] RIJK J M, ROOS P R, DECKX L, et al. Prognostic value of handgrip strength in people aged 60 years and older: A systematic review and meta-analysis[J]. Geriatr Gerontol Int,2016,16(1):5-20. [17] 中华医学会老年医学分会老年康复学组, 肌肉衰减综合征专家共识撰写组. 肌肉衰减综合征中国专家共识(草案)[J]. 中华老年医学杂志,2017,36(7):711-718. [18] BHASIN S, TRAVISON T G, MANINI T M, et al. Sarcopenia Definition: The position statements of the sarcopenia definition and outcomes consortium[J]. J Am Geriatr Soc,2020,68(7):1410-1418. [19] UNGER T, BORGHI C, CHARCHARr F, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines[J]. Hypertension,2020,75(6):1334-1357. |